Evidence map›Paper›PMID 37838782›Full record

ArticleNature communications2023

Apparent symmetry rising induced by crystallization inhibition in ternary co-crystallization-driven self-assembly.

Siyu Xie, Wenjia Sun, Junliang Sun, Xinhua Wan, Jie Zhang

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siyu XieBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China.ORCID http://orcid.org/0000-0002-8225-0403
Wenjia SunBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China.
Junliang SunBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China.ORCID http://orcid.org/0000-0003-4074-0962
Xinhua WanBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China.ORCID http://orcid.org/0000-0003-2851-6650
Jie ZhangBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China. jz10@pku.edu.cn.ORCID http://orcid.org/0000-0002-6509-8614

Funding

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) 22375009National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) 52073001
6 · The paper itself

Abstract

The concept of apparent symmetry rising, opposite to symmetry breaking, was proposed to illustrate the unusual phenomenon that the symmetry of the apparent morphology of the multiply twinned particle is higher than that of its crystal structure. We developed a unique strategy of co-crystallization-driven self-assembly of amphiphilic block copolymers PEO-b-PS and the inorganic cluster silicotungstic acid to achieve apparent symmetry rising of nanoparticles under mild conditions. The triangular nanoplates triply twinned by orthogonal crystals (low symmetry) have an additional triple symmetry (high symmetry). The appropriate crystallization inhibition of short solvophilic segments of the block copolymers favors the oriented attachment of homogeneous domains of hybrid nanoribbons, and consequently forms kinetic-controlled triangular nanoplates with twin grain boundaries.

Identifiers

PMID37838782
PMCPMC10576807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.